Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study.

Satoshi YoshijiMasashi HasebeYorihiro IwasakiKimitaka ShibueYamato KeidaiYohei SenoKanako IwasakiSachiko HonjoJun FujikawaAkihiro Hamasaki

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

Fasting and meal-induced C-peptide levels are associated with glycemic response to dulaglutide, among which FCPR is least confounded by baseline glycemic control, suggesting its utility as a marker for glycemic response to dulaglutide.

Keyphrases

glycemic control
type diabetes
blood glucose
insulin resistance
weight loss
high glucose
adipose tissue
metabolic syndrome
blood pressure
skeletal muscle
endothelial cells
oxidative stress